Douglas Miehm Analyst PerformanceAnalyst at Royal Bank Of CanadaDouglas Miehm is a stock analyst at Royal Bank Of Canada, covering 11 publicly traded companies across a range of sectors. Over the past year, Douglas Miehm has issued 11 stock ratings, including buy and hold recommendations. While full access to Douglas Miehm's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Douglas Miehm's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings84 Last 10 YearsBuy Recommendations51.81% 43 Buy RatingsCompanies Covered11 Unique Companies Ratings Distribution83RatingsDistribution of strong buy, buy, hold, and sell ratings by Douglas Miehm.RatingPercentageCount Strong Buy0.0%0 ratings Buy51.8%43 ratings Hold48.2%40 ratings Sell0.0%0 ratingsOut of 83 total stock ratings issued by Douglas Miehm at Royal Bank Of Canada, the majority (51.8%) have been Buy recommendations, followed by 48.2% Hold.Best & Worst CallsBest Call000.0%AUPHDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHCJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.6% of companies on NASDAQ7 companiesNYSE18.2% of companies on NYSE2 companiesTSE9.1% of companies on TSE1 companyOTCMKTS9.1% of companies on OTCMKTS1 companyDouglas Miehm, an analyst at Royal Bank Of Canada, currently covers 11 companies listed on NASDAQ, NYSE, TSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical10 companies90.9%Miscellaneous1 company9.1%Douglas Miehm of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE3 companies27.3%PHARMACEUTICAL PREPARATIONS3 companies27.3%MED - DRUGS1 company9.1%MED - GENERIC DRG1 company9.1%MEDICAL SERVICES1 company9.1%MEDICAL INSTRUMENTS & SUPPLIES1 company9.1%Miscellaneous1 company9.1% Douglas Miehm's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMNKDMannKind8/26/2025Boost Price Target$3.95$8.00Outperform$0.0000.00% ROILGNDLigand Pharmaceuticals8/8/2025Boost Price Target$150.84$185.00Outperform$0.0000.00% ROIMNKDMannKind8/7/2025Lower Price Target$3.42$7.00Outperform$0.0000.00% ROIAUPHAurinia Pharmaceuticals8/1/2025Boost Price Target$10.01$9.00Outperform$0.0000.00% ROIMNKDMannKind7/23/2025Lower Price Target$3.93$8.00Outperform$0.0000.00% ROIBHCBausch Health Cos5/2/2025Boost Price Target$5.45$10.00Sector Perform$0.0000.00% ROIBLCOBausch + Lomb4/4/2025Lower Price Target$12.32$17.00Outperform$0.0000.00% ROIONCYOncolytics Biotech3/10/2025Lower Price Target$0.66$5.00Outperform$0.0000.00% ROIBLCOBausch + Lomb2/20/2025Lower Price Target$16.11$18.00Outperform$0.0000.00% ROIBHCBausch Health Cos1/30/2025Lower Price Target$7.41$10.00Sector Perform$0.0000.00% ROIBLCOBausch + Lomb1/29/2025Lower Price Target$17.79$22.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.